You are here: Industry Insights > Japan

News List

Takeda submits New Drug Application for lanadelumab in Japan pharmaceutical-business-review
March 18, 2021
Japan-based, R&D-driven Takeda Pharmaceutical Company Limited has submitted a New Drug Application (NDA) for lanadelumab to the Ministry of Health, Labour and Welfare (MHLW) in Japan.
Japan Health Ministry finds new coronavirus variant expresspharma
January 12, 2021
The variant was identified in airport tests on a man in his 40s, a woman in her 30s and two teens, the ministry said.
LYNPARZA (olaparib) get three new approvals in Japan expresspharma
December 29, 2020
Approvals in three types of cancer are based on the PAOLA-1, PROfound and POLO Phase 3 Trials.
Forxiga Approved in Japan for Chronic Heart Failure americanpharmaceuticalreview
December 16, 2020
AstraZeneca’s Forxiga (dapagliflozin) has been approved in Japan for the treatment of patients with chronic heart failure (HF) who are receiving standard of care.
Sai Life Sciences opens representative office in Tokyo, Japan expresspharma
November 23, 2020
Sai Life Sciences, an Indian Contract Research, Development & Manufacturing Organisation (CRO-CDMO), announced the opening of its representative office in Tokyo, Japan.
Moderna partners with Takeda for Covid-19 vaccines supply to Japan pharmaceutical-technology
November 02, 2020
Moderna has announced that the Ministry of Health, Labour and Welfare of Japan (MHLW) and Takeda Pharmaceutical agreed to purchase and distribute 50 million doses of its Covid-19 vaccine candidate, mRNA-1273.
Japan’s cabinet approves plan for free COVID-19 vaccines expresspharma
October 29, 2020
Japan’s cabinet approved a plan on Tuesday to use public funds to provide novel coronavirus vaccines to the public for free.
COVID-19 Vaccine Trial Resumed in Japan americanpharmaceuticalreview
October 10, 2020
The Phase I/II clinical trial for the COVID-19 vaccine AZD1222 has resumed in Japan after discussion with the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).
Top six CROs on Japanese market revealed in new report europeanpharmaceuticalreview
October 09, 2020
Researchers have revealed the top six CROs that dominate the Japanese market and are expected to continue in their position.
Avigan Shows Promising Results in Treatment of COVID Patients in Japan americanpharmaceuticalreview
September 30, 2020
Global Response Aid (GRA) and Dr. Reddy's Laboratories announced the anti-viral drug Avigan® produced promising results in a single-blinded, placebo-controlled Phase 3 clinical study conducted in Japan with the sponsorship of FujiFilm Toyama Chemical.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page